Oberweis Asset Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Oberweis Asset Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-3,000	Closed	-$339K	–	189
2017 Q2	$339K	Sell	3,000 -32,385	-92%	-$3.62M	0.09%	120
2017 Q1	$3.54M	Sell	35,385 -20,470	-37%	-$2.19M	1.04%	35
2016 Q4	$6.01M	Sell	55,855 -7,450	-12%	-$871K	1.79%	18
2016 Q3	$7.88M	Sell	63,305 -19,470	-24%	-$2.3M	2.27%	9
2016 Q2	$8.8M	Sell	82,775 -7,330	-8%	-$851K	2.62%	8
2016 Q1	$10.3M	Buy	90,105 +5,220	+6%	+$612K	2.98%	3
2015 Q4	$12.1M	Buy	84,885 +21,885	+35%	+$2.53M	3.39%	3
2015 Q3	$5.66M	Buy	63,000 +9,500	+18%	+$1M	1.65%	28
2015 Q2	$6.16M	Sell	53,500 -2,700	-5%	-$284K	1.63%	29
2015 Q1	$5.37M	Buy	56,200 +6,200	+12%	+$464K	1.51%	27
2014 Q4	$3.36M	Buy	+50,000	New	+$3.1M	1%	33

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Oberweis Asset Management's CBPO Position: Q3 2017 in Review

Oberweis Asset Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2017, closing a stake of 3,000 shares — an estimated $339K sold.

Oberweis Asset Management first reported a position in CBPO in Q4 2014 and held it in 11 quarters. The position peaked at $12.1M in Q4 2015. 94 funds tracked by Wall St. Rank hold CBPO as of Q3 2017.

Oberweis Asset Management reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2017 after selling out during the quarter.
Oberweis Asset Management sold 3,000 China Biologic Products Holdings, Inc. shares in Q3 2017, an estimated $339K.
Oberweis Asset Management first reported a position in China Biologic Products Holdings, Inc. in Q4 2014 and held it in 11 quarters.
Oberweis Asset Management's China Biologic Products Holdings, Inc. position peaked at $12.1M in Q4 2015.
94 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2017.

Based on Oberweis Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.